5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol

C126H198F2N22O2 — CID 167609409

IUPAC5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol
SMILESCC(C)(C)c1ccc(N2CCC(F)(F)CC2)nc1.CC(C)(C)c1ccc(N2CCC(O)CC2)nc1.CC(C)(C)c1ccc(N2CCCCC2)nc1.CC(C)(C)c1ccc(N2CCNCC2)nc1.CC(C)(C)c1ccc(N2CCOCC2)nc1.CCN1CCN(c2ccc(C(C)(C)C)cn2)CC1.CN1CC=C(c2ccc(C(C)(C)C)cn2)CC1.CN1CCN(c2ccc(C(C)(C)C)cn2)CC1.CN1CCN(c2ccc(C(C)(C)C)cn2)CC1
InChIInChI=1S/C15H25N3.C15H22N2.C14H20F2N2.2C14H23N3.C14H22N2O.C14H22N2.C13H21N3.C13H20N2O/c1-5-17-8-10-18(11-9-17)14-7-6-13(12-16-14)15(2,3)4;1-15(2,3)13-5-6-14(16-11-13)12-7-9-17(4)10-8-12;1-13(2,3)11-4-5-12(17-10-11)18-8-6-14(15,16)7-9-18;2*1-14(2,3)12-5-6-13(15-11-12)17-9-7-16(4)8-10-17;1-14(2,3)11-4-5-13(15-10-11)16-8-6-12(17)7-9-16;1-14(2,3)12-7-8-13(15-11-12)16-9-5-4-6-10-16;1-13(2,3)11-4-5-12(15-10-11)16-8-6-14-7-9-16;1-13(2,3)11-4-5-12(14-10-11)15-6-8-16-9-7-15/h6-7,12H,5,8-11H2,1-4H3;5-7,11H,8-10H2,1-4H3;4-5,10H,6-9H2,1-3H3;2*5-6,11H,7-10H2,1-4H3;4-5,10,12,17H,6-9H2,1-3H3;7-8,11H,4-6,9-10H2,1-3H3;4-5,10,14H,6-9H2,1-3H3;4-5,10H,6-9H2,1-3H3
InChIKeyKVGHNVYABIDFHI-UHFFFAOYSA-N
MW2091.12 g/mol
LogP23.21
Rot. Bonds10

About 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol

5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol (PubChem CID 167609409) has the molecular formula C126H198F2N22O2 and a molecular weight of 2091.12 g/mol. Its IUPAC name is 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol.

Molecular Properties

Compound Name5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol
PubChem CID167609409
Molecular FormulaC126H198F2N22O2
Molecular Weight2091.12 g/mol
Exact Mass2089.60
IUPAC Name5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol
SMILESCC(C)(C)c1ccc(N2CCC(F)(F)CC2)nc1.CC(C)(C)c1ccc(N2CCC(O)CC2)nc1.CC(C)(C)c1ccc(N2CCCCC2)nc1.CC(C)(C)c1ccc(N2CCNCC2)nc1.CC(C)(C)c1ccc(N2CCOCC2)nc1.CCN1CCN(c2ccc(C(C)(C)C)cn2)CC1.CN1CC=C(c2ccc(C(C)(C)C)cn2)CC1.CN1CCN(c2ccc(C(C)(C)C)cn2)CC1.CN1CCN(c2ccc(C(C)(C)C)cn2)CC1
InChIInChI=1S/C15H25N3.C15H22N2.C14H20F2N2.2C14H23N3.C14H22N2O.C14H22N2.C13H21N3.C13H20N2O/c1-5-17-8-10-18(11-9-17)14-7-6-13(12-16-14)15(2,3)4;1-15(2,3)13-5-6-14(16-11-13)12-7-9-17(4)10-8-12;1-13(2,3)11-4-5-12(17-10-11)18-8-6-14(15,16)7-9-18;2*1-14(2,3)12-5-6-13(15-11-12)17-9-7-16(4)8-10-17;1-14(2,3)11-4-5-13(15-10-11)16-8-6-12(17)7-9-16;1-14(2,3)12-7-8-13(15-11-12)16-9-5-4-6-10-16;1-13(2,3)11-4-5-12(15-10-11)16-8-6-14-7-9-16;1-13(2,3)11-4-5-12(14-10-11)15-6-8-16-9-7-15/h6-7,12H,5,8-11H2,1-4H3;5-7,11H,8-10H2,1-4H3;4-5,10H,6-9H2,1-3H3;2*5-6,11H,7-10H2,1-4H3;4-5,10,12,17H,6-9H2,1-3H3;7-8,11H,4-6,9-10H2,1-3H3;4-5,10,14H,6-9H2,1-3H3;4-5,10H,6-9H2,1-3H3
InChIKeyKVGHNVYABIDFHI-UHFFFAOYSA-N
XLogP23.21
TPSA196.38 Ų
H-Bond Donors2
H-Bond Acceptors24
Rotatable Bonds10
Heavy Atoms152
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002091.12
LogP ≤ 523.21
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1024

Analyze 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-[4-[6-[(4,4-dimethylpiperidin-1-yl)methyl]pyridin-3-yl]-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl]-N-(phenylmethyl)pyrimidin-4-amine
CID 156587340
4-(1-Piperazin-1-yl[2,6]naphthyridin-3-yl)pyridin-2-yl](tetrahydropyran-4-yl)amine
CID 46899901
{4-[1-(4-Isobutylpiperazin-1-yl)[2,6]naphthyridin-3-yl]pyridin-2-yl}(tetrahydropyran-4-yl)amine
CID 46899902
1-[3-(2-Cyclohexylaminopyridin-4-yl)[2,6]naphthyridin-1-yl]piperidin-4-ol
CID 46900065
(2R)-2-[[3-fluoro-6-(5-methyl-6-morpholin-4-yl-3-pyridinyl)-2-pyridinyl]methylamino]-3-methylbutan-1-ol
CID 68312395
4-methyl-6-(6-morpholin-4-yl-3-pyridinyl)-N-[4-(trifluoromethyl)-2-pyridinyl]pyridin-2-amine
CID 119098921
(S)-1-(4-(5-(morpholin-2-ylmethylamino)pyrido[4,3-b]pyrazin-7-yl)phenyl)piperidin-4-ol
CID 86717401
(2R)-2-[[3-fluoro-6-(2-morpholin-4-yl-4-pyridinyl)-2-pyridinyl]methylamino]-3-methylbutan-1-ol
CID 68312540
N-[(6-morpholin-4-yl-2-pyridinyl)methyl]-5-pyridin-4-ylpyridin-2-amine
CID 139019312
2-[(2,6-dimethylmorpholin-4-yl)methyl]-7-[3-(trifluoromethyl)pyridin-2-yl]-N-[6-(trifluoromethyl)pyridin-3-yl]pyrido[3,2-d]pyrimidin-4-amine
CID 22030068
N-(4-tert-butylphenyl)-2-[(2,6-dimethylmorpholin-4-yl)methyl]-7-[3-(trifluoromethyl)pyridin-2-yl]pyrido[3,2-d]pyrimidin-4-amine
CID 22030114
N-(4-tert-butylphenyl)-2-[(2,6-dimethylmorpholin-4-yl)methyl]-7-[3-(trifluoromethyl)pyridin-2-yl]pyrido[2,3-d]pyrimidin-4-amine
CID 22030246

Frequently Asked Questions

What is the IUPAC name of 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol?
The IUPAC name of 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol (CID 167609409) is 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol.
What is the SMILES notation for 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol?
The canonical SMILES for 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol is CC(C)(C)c1ccc(N2CCC(F)(F)CC2)nc1.CC(C)(C)c1ccc(N2CCC(O)CC2)nc1.CC(C)(C)c1ccc(N2CCCCC2)nc1.CC(C)(C)c1ccc(N2CCNCC2)nc1.CC(C)(C)c1ccc(N2CCOCC2)nc1.CCN1CCN(c2ccc(C(C)(C)C)cn2)CC1.CN1CC=C(c2ccc(C(C)(C)C)cn2)CC1.CN1CCN(c2ccc(C(C)(C)C)cn2)CC1.CN1CCN(c2ccc(C(C)(C)C)cn2)CC1.
What is the InChIKey of 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol?
The InChIKey is KVGHNVYABIDFHI-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H25N3.C15H22N2.C14H20F2N2.2C14H23N3.C14H22N2O.C14H22N2.C13H21N3.C13H20N2O/c1-5-17-8-10-18(11-9-17)14-7-6-13(12-16-14)15(2,3)4;1-15(2,3)13-5-6-14(16-11-13)12-7-9-17(4)10-8-12;1-13(2,3)11-4-5-12(17-10-11)18-8-6-14(15,16)7-9-18;2*1-14(2,3)12-5-6-13(15-11-12)17-9-7-16(4)8-10-17;1-14(2,3)11-4-5-13(15-10-11)16-8-6-12(17)7-9-16;1-14(2,3)12-7-8-13(15-11-12)16-9-5-4-6-10-16;1-13(2,3)11-4-5-12(15-10-11)16-8-6-14-7-9-16;1-13(2,3)11-4-5-12(14-10-11)15-6-8-16-9-7-15/h6-7,12H,5,8-11H2,1-4H3;5-7,11H,8-10H2,1-4H3;4-5,10H,6-9H2,1-3H3;2*5-6,11H,7-10H2,1-4H3;4-5,10,12,17H,6-9H2,1-3H3;7-8,11H,4-6,9-10H2,1-3H3;4-5,10,14H,6-9H2,1-3H3;4-5,10H,6-9H2,1-3H3.
What are the key properties of 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol?
5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol has a molecular weight of 2091.12 g/mol, XLogP of 23.21, 10 rotatable bonds, 2 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 5-tert-butyl-2-(4,4-difluoropiperidin-1-yl)pyridine;5-tert-butyl-2-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)pyridine;5-tert-butyl-2-piperidin-1-ylpyridine;1-(5-tert-butyl-2-pyridinyl)-4-ethylpiperazine;bis(1-(5-tert-butyl-2-pyridinyl)-4-methylpiperazine);4-(5-tert-butyl-2-pyridinyl)morpholine;1-(5-tert-butyl-2-pyridinyl)piperazine;1-(5-tert-butyl-2-pyridinyl)piperidin-4-ol is sourced from PubChem (CID 167609409), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).